Literature DB >> 6304423

Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.

V W Hanson, M H Buonarati, R C Baselt, N A Wade, C Yep, A A Biasotti, V C Reeve, A S Wong, M W Orbanowsky.   

Abstract

Blood and serum specimens from 100 subjects in a driving study were tested for the presence of delta 9-tetrahydrocannabinol (THC) by 3H- and 125I-labeled RIA and GC/MS. The specimens were also analyzed for 11-nor-9-carboxy-delta 9-tetrahydrocannabinol by the two RIA methods. Blind quality control specimens containing THC were included with each batch of subject specimens and sent coded to three participating laboratories. The methods were assessed for accuracy, reproducibility, detectability, specificity, and the results correlated. It was found that serum was a better matrix than blood for determination of cannabinoids. The three methods gave parallel but significantly different quantitative results, apparently due to calibration problems. However, each technique was capable of measuring THC concentrations up to three hours after usage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304423     DOI: 10.1093/jat/7.2.96

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  4 in total

Review 1.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 2.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  [Tetrahydrocannabinols in hair of hashish smokers].

Authors:  S Balabanova; P J Arnold; V Luckow; H Brunner; H U Wolf
Journal:  Z Rechtsmed       Date:  1989

4.  Drugs in fatally injured young male drivers.

Authors:  A F Williams; M A Peat; D J Crouch; J K Wells; B S Finkle
Journal:  Public Health Rep       Date:  1985 Jan-Feb       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.